MetLife (MET)
(Delayed Data from NYSE)
$80.74 USD
+0.29 (0.36%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $80.74 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
A Value D Growth C Momentum B VGM
Income Statements
Fiscal Year end for MetLife, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 66,905 | 69,898 | 71,080 | 67,842 | 69,620 |
Cost Of Goods | 52,078 | 55,005 | 50,368 | 47,765 | 49,136 |
Gross Profit | 14,827 | 14,893 | 20,712 | 20,077 | 20,484 |
Selling & Adminstrative & Depr. & Amort Expenses | 12,665 | 12,034 | 12,586 | 13,150 | 13,689 |
Income After Depreciation & Amortization | 2,162 | 2,859 | 8,126 | 6,927 | 6,795 |
Non-Operating Income | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 2,162 | 2,859 | 8,126 | 6,927 | 6,795 |
Income Taxes | 560 | 301 | 1,551 | 1,509 | 886 |
Minority Interest | 24 | 19 | 21 | 11 | 10 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 1,602 | 2,558 | 6,575 | 5,418 | 5,909 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 1,578 | 2,539 | 6,554 | 5,407 | 5,899 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 1,548 | 2,572 | 7,965 | 6,730 | 6,426 |
Depreciation & Amortization (Cash Flow) | -614 | -287 | -161 | -197 | -369 |
Income After Depreciation & Amortization | 2,162 | 2,859 | 8,126 | 6,927 | 6,795 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 762.30 | 808.90 | 869.40 | 913.91 | 944.40 |
Diluted EPS Before Non-Recurring Items | 7.33 | 6.85 | 9.15 | 6.16 | 6.11 |
Diluted Net EPS (GAAP) | 1.81 | 2.91 | 7.31 | 5.68 | 6.06 |
Fiscal Year end for MetLife, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 17,823.00 | 16,057.00 | 19,028.00 | 15,866.00 | 16,623.00 |
Cost Of Goods | 13,451.00 | 11,817.00 | 14,774.00 | 12,145.00 | 13,076.00 |
Gross Profit | 4,372.00 | 4,240.00 | 4,254.00 | 3,721.00 | 3,547.00 |
SG&A, R&D, and Dept/Amort Expenses | 3,170.00 | 3,195.00 | 3,313.00 | 3,187.00 | 3,117.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 1,202.00 | 1,045.00 | 941.00 | 534.00 | 430.00 |
Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | 1,202.00 | 1,045.00 | 941.00 | 534.00 | 430.00 |
Income Taxes | 249.00 | 170.00 | 327.00 | 39.00 | 22.00 |
Minority Interest | 7.00 | 8.00 | 7.00 | 6.00 | 6.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 953.00 | 875.00 | 614.00 | 495.00 | 408.00 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 946.00 | 867.00 | 607.00 | 489.00 | 402.00 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 714.70 | 728.40 | 743.40 | 755.50 | 769.60 |
Diluted EPS Before Non-Recurring Items | 2.28 | 1.83 | 1.93 | 1.97 | 1.94 |
Diluted Net EPS (GAAP) | 1.28 | 1.10 | 0.75 | 0.56 | 0.48 |